@article{article, title  = {{Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2026.44.16_suppl.4504 }},

 year = {{2026}},

 month = {{5}},

 author = {{James ND and van de Wiel J and De Santis M and Din OS and Ford D and Hafeez S and Huddart RA and Hughes A and Iddenden J and Mir R and Vassallo - Bonner C et al}},

 doi = {{10.1200/jco.2026.44.16_suppl.4504}},

 volume = {{44}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{16_suppl}},

 pages = {{4504-4504}},

 note = {{Accessed on 2026/06/23}}}